Page results
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
Information for patients and visitors on patient isolation.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma